Colloidal bismuth subcitrate

Information about Colloidal bismuth subcitrate

Colloidal bismuth subcitrate uses

Colloidal bismuth subcitrate is used in the treatment of Peptic ulcer disease.

How colloidal bismuth subcitrate works

Colloidal bismuth subcitrate is believed to work by several methods. First, it increases in mucus glycoprotein secretion and may also bind to the gastric mucus layer to act as a diffusion barrier to HCl. It is also known to have cytoprotective effect and enhances mucosal secretion of prostaglandins and bicarbonate.

Common side effects of colloidal bismuth subcitrate

Black tongue, Dark colored stool, Nausea, Vomiting, Bone toxicity, Joint toxicity, Bismuth poisoning, Encephalopathy, Renal failure, Liver damage

Available Medicine for Colloidal bismuth subcitrate

  • ₹230
    Ingram Biosciences Pvt Ltd
    1 variant(s)
  • ₹195
    Enactis Healthcare Pvt Ltd
    1 variant(s)
  • ₹220
    Waterley Pharmaceuticals Pvt Ltd
    1 variant(s)
  • ₹192
    San Fegan Biotech Pvt Ltd
    1 variant(s)
  • ₹208
    Olympus Life Sciences
    1 variant(s)
  • ₹205
    Invig Healthcare Pvt Ltd
    1 variant(s)

Content on this page was last updated on 22 August, 2022, by Dr. Varun Gupta (MD Pharmacology)